Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

James Edward Muller, M.D.

Co-Author

This page shows the publications co-authored by James Muller and Peter Stone.
Connection Strength

1.203
  1. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989 Apr; 79(4):733-43.
    View in: PubMed
    Score: 0.098
  2. Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size. Ann Intern Med. 1988 Jan; 108(1):1-6.
    View in: PubMed
    Score: 0.090
  3. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987 Jan; 75(1):131-8.
    View in: PubMed
    Score: 0.084
  4. Circadian variation of cardiovascular disease and sympathetic activity. J Cardiovasc Pharmacol. 1987; 10 Suppl 2:S104-9; discussion S110-1.
    View in: PubMed
    Score: 0.084
  5. Nifedipine therapy for coronary vasospasm. Arch Mal Coeur Vaiss. 1983 Feb; 76 Spec No:137-42.
    View in: PubMed
    Score: 0.064
  6. Efficacy of nifedipine therapy for refractory angina pectoris. Am Heart J. 1982 Sep; 104(3):672-81.
    View in: PubMed
    Score: 0.062
  7. Nifedipine therapy for recurrent ischemic pain following myocardial infarction. Clin Cardiol. 1982 Mar; 5(3):223-30.
    View in: PubMed
    Score: 0.060
  8. Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2020 10 20; 21(11):1177-1183.
    View in: PubMed
    Score: 0.055
  9. Vulnerable plaques and patients: state-of-the-art. Eur Heart J. 2020 08 14; 41(31):2997-3004.
    View in: PubMed
    Score: 0.054
  10. Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. J Am Coll Cardiol. 1998 Nov 15; 32(6):1680-6.
    View in: PubMed
    Score: 0.048
  11. Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology. Eur Heart J. 2017 02 07; 38(6):400-412.
    View in: PubMed
    Score: 0.042
  12. Use of skin conductance changes during mental stress testing as an index of autonomic arousal in cardiovascular research. Am Heart J. 1994 Dec; 128(6 Pt 1):1170-7.
    View in: PubMed
    Score: 0.036
  13. Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand. Circulation. 1994 Feb; 89(2):604-14.
    View in: PubMed
    Score: 0.034
  14. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990 Jul 01; 66(1):22-7.
    View in: PubMed
    Score: 0.027
  15. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol. 1989 Jul; 14(1):49-57.
    View in: PubMed
    Score: 0.025
  16. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease. Circulation. 1989 Mar; 79(3):557-65.
    View in: PubMed
    Score: 0.024
  17. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol. 1988 Mar; 11(3):453-63.
    View in: PubMed
    Score: 0.023
  18. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987 Oct 01; 60(10):801-6.
    View in: PubMed
    Score: 0.022
  19. Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction. J Am Coll Cardiol. 1986 Nov; 8(5):1007-17.
    View in: PubMed
    Score: 0.021
  20. Use of calcium channel blocking agents in the management of ischaemic heart disease. Eur Heart J. 1985 Jan; 6 Suppl A:31-6.
    View in: PubMed
    Score: 0.018
  21. Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation. 1984 Apr; 69(4):728-39.
    View in: PubMed
    Score: 0.017
  22. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984 Apr; 69(4):740-7.
    View in: PubMed
    Score: 0.017
  23. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. Arq Bras Cardiol. 1983 Dec; 41(6):469-76.
    View in: PubMed
    Score: 0.017
  24. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol. 1983 Nov 01; 52(8):936-42.
    View in: PubMed
    Score: 0.017
  25. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003 Oct 14; 108(15):1772-8.
    View in: PubMed
    Score: 0.017
  26. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 07; 108(14):1664-72.
    View in: PubMed
    Score: 0.017
  27. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. Am Heart J. 1983 Oct; 106(4 Pt 1):644-52.
    View in: PubMed
    Score: 0.017
  28. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am J Cardiol. 1997 Feb 01; 79(3):253-8.
    View in: PubMed
    Score: 0.011
  29. Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol. 1993 May 01; 71(12):1031-5.
    View in: PubMed
    Score: 0.008
  30. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol. 1992 Nov 01; 20(5):1049-55.
    View in: PubMed
    Score: 0.008
  31. Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS Study Group. Am Heart J. 1991 May; 121(5):1374-81.
    View in: PubMed
    Score: 0.007
  32. Mortality for women after acute myocardial infarction: MILIS Study Group. Am J Cardiol. 1989 Jul 15; 64(3):256.
    View in: PubMed
    Score: 0.006
  33. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol. 1989 Jul; 14(1):40-6; discussion 47-8.
    View in: PubMed
    Score: 0.006
  34. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J. 1989 Apr; 117(4):809-18.
    View in: PubMed
    Score: 0.006
  35. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J. 1989 Jan; 117(1):86-92.
    View in: PubMed
    Score: 0.006
  36. Rate of disappearance of creatine kinase-MB after acute myocardial infarction: clinical determinants of variability. Am Heart J. 1988 Dec; 116(6 Pt 1):1493-9.
    View in: PubMed
    Score: 0.006
  37. Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients. Am J Cardiol. 1988 Nov 01; 62(13):860-7.
    View in: PubMed
    Score: 0.006
  38. Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J. 1988 Jul; 116(1 Pt 1):23-31.
    View in: PubMed
    Score: 0.006
  39. High-risk subgroups of patients with non-Q wave myocardial infarction based on direction and severity of ST segment deviation. Am Heart J. 1987 Nov; 114(5):1110-9.
    View in: PubMed
    Score: 0.006
  40. Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarction. J Am Coll Cardiol. 1987 Nov; 10(5):979-90.
    View in: PubMed
    Score: 0.006
  41. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size. Am J Cardiol. 1987 Oct 01; 60(10):755-61.
    View in: PubMed
    Score: 0.006
  42. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987 Mar; 9(3):473-82.
    View in: PubMed
    Score: 0.005
  43. Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol. 1986 Aug 01; 58(3):203-9.
    View in: PubMed
    Score: 0.005
  44. A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol. 1986 Jun 01; 57(15):1213-9.
    View in: PubMed
    Score: 0.005
  45. Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (A MILIS Study). Am J Cardiol. 1985 Jun 01; 55(13 Pt 1):1463-8.
    View in: PubMed
    Score: 0.005
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.